NCT00799227View on ClinicalTrials.gov

Safety and Efficacy of a New Treatment in Vitrectomized Subjects With Diabetic Macular Edema

PHASE2CompletedINTERVENTIONAL

Enrollment

56

Participants

Timeline

Start Date

January 1, 2009

Primary Completion Date

December 1, 2009

Study Completion Date

December 1, 2009

Conditions

Diabetic Macular EdemaVitrectomy

Interventions

DRUG

Dexamethasone

700 µg Dexamethasone Posterior Segment Drug Delivery System Applicator System at Day 1 in the study eye.

Trial Locations (2)

Unknown

Charlotte

Sydney

Sponsors

Lead Sponsor

All Listed Sponsors

lead

Allergan

INDUSTRY